Hottub News

Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD

1 report from 1 outlet in 1 language · first reported · updated · JSON

Healthgastroesophageal reflux disease

Reports

  1. Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERDGlobeNewswire — public companies · en ·

More in Health

  1. Russian researcher ‘dies of plague released by lab accident’53 outlets
  2. Nobel Prize week to begin with the medicine award33 outlets
  3. Russian Researcher Dies Of Plague, Hundreds Quarantined, 5 Hospitals Shut31 outlets
  4. Donna Manton: How ketamine therapy helped an ADF veteran heal | Bega District News51 outlets
  5. Climate change raises major disease risks for Australia33 outlets
  6. Nobel Prize in Medicine awarded to Deisseroth, Hegemann, and Nagel for neuron research23 outlets